James T. Murray, MA, MPP
Affiliations: | 2013-2015 | Philosophy | Queen's University, Kingston, ON, Canada |
Area:
Self-Defense ethics, desert considerationsGoogle:
"James Murray Beyond Moral Responsibility and Lesser Evils Queen's University"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Maragno AL, Mistry P, Kotschy A, et al. (2019) Abstract 4482: S64315 (MIK665) is a potent and selective Mcl1 inhibitor with strong antitumor activity across a diverse range of hematologic tumor models Cancer Research. 79: 4482-4482 |
| Murray JT, Tee AR. (2018) Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting. Cancers. 10 |
| Rad E, Murray JT, Tee AR. (2018) Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression. Cancers. 10 |
| Klionsky DJ, Abdelmohsen K, Abe A, et al. (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222 |
| Diez-Cecilia E, Carson R, Kelly B, et al. (2015) Probing a 3,4'-bis-guanidinium diaryl derivative as an allosteric inhibitor of the Ras pathway. Bioorganic & Medicinal Chemistry Letters. 25: 4287-92 |
| Moore JD, Staniszewska A, Shaw T, et al. (2014) VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. Oncotarget. 5: 12862-76 |
| Huang YH, Al-Aidaroos AQ, Yuen HF, et al. (2014) A role of autophagy in PTP4A3-driven cancer progression. Autophagy. 10: 1787-800 |
| Dunlop EA, Seifan S, Claessens T, et al. (2014) FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation. Autophagy. 10: 1749-60 |
| D'Costa ZC, Higgins C, Ong CW, et al. (2014) TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities. Oncotarget. 5: 1609-20 |
| Matchett KB, McFarlane S, Hamilton SE, et al. (2014) Ran GTPase in nuclear envelope formation and cancer metastasis. Advances in Experimental Medicine and Biology. 773: 323-51 |